The Managing Patients with Limited Treatment Options - EU Series Second Edition is comprised of editions in three languages with local experts to cover the latest treatment options tailored to regional needs.
Meeting category
Date(s)
31 Oct 2022 - 24 Nov 2022
Important dates
Spanish Edition
31 October 2022
German Edition
14 November 2022
Italian Edition
24 November 2022
Meeting type
Virtual Meeting
Organizer
Managing HIV Patients with Limited Treatment Options - EU Series 2022 Second Edition
Related Enduring Materials
Enduring Material
Program
Spanish Edition - 31 October - 17:00
Josep Llibre, MD, PhD
Josep Llibre, MD, PhD
Josep Llibre, MD, PhD
Nuria Espinosa Aguilera, PhD
Josep Llibre, MD, PhD
17:00 CET
Palabras de Apertura
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
17:05 CET
Manejo de PLWHIV en Pacientes con Tratamientos Limitados
17:25 CET
Debate
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
Debate Sobre Casos Clínicos
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
17:35 CET
Caso Clínico 1
17:50 CET
Caso Clínico 2
Clinical Unit of Infectious Diseases, Microbiology and Parasitology, Hospital Virgen del Rocio, Seville, Spain
18:05 CET
Caso Clínico 3
18:20 CET
Conclusiones y Aclaraciones I Lecciones Aprendidas
Fundació Lluita contra la Sida; Hospital Universitari Germans Trias i Pujol, Spain
German Edition - 14 November - 18:30
18:30 CET
Begrüßung
18:35 CET
Betreuung von HIV-Patienten mit eingeschränkten Therapieoptionen
18:55 CET
Diskussionsrunde
Klinische Fallstudien - Moderierte Diskussionsrunde
19:05 CET
Klinischer Fall 1
19:20 CET
Klinischer Fall 2
19:35 CET
Klinischer Fall 3
19:50 CET
Zusammenfassung / Lernerfolgskontrolle
Italian Edition - 24 November - 17:30
Marianna Menozzi, MD
17:30 CET
Introduzione ai Lavori
17:35 CET
La Gestione di Percorsi Terapeutici Per Pazienti Con Opzioni Terapeutiche Limitate
17:55 CET
Discussione
18:05 CET
Discussione su Casi Clinici
18:05
Caso Clinico 1
Micol Ferrara
Ospedale San Raffaele S.r.l., Italy
18:20
Caso Clinico 2
Infectious Disease Clinic at Azienda Ospedaliero Universitaria Policlinico di Modena
18:35
Caso Clinico 3
18:50 CET
Discussione e Commenti Finali
General
Welcome
Are you interested in learning more about optimal care for people living with HIV with limited treatment options?
The second edition of this program will address available tools to identify these patients, explore resistance considerations in treatment decisions, and discuss how to tackle polypharmacy, drug-drug interactions, co-morbidities, and more!
You will gain insights into new treatment options and how best to integrate them into optimal antiretroviral regimens.
This webinar series is comprised of three editions, each in a different language, all featuring both regional and international experts.
We invite you to join us virtually this autumn at one of the following editions:
- Spanish - 31 October
- German - 14 November
- Italian - 24 November
Program Director
General Information
COVID-19 Update
Responding to the changing COVID-19 situation, the Managing HIV Patients with Limited Treatment Options - EU Series 2022 will be held as three virtual webinars.
We are available to answer any questions or concerns that you may have about your participation at the Managing HIV Patients with Limited Treatment Options - EU Series 2022.
For more information, please contact Paula Janiak at paula.janiak@amededu.com.
We are available to answer any questions or concerns that you may have about your participation at the Managing HIV Patients with Limited Treatment Options - EU Series 2022.
For more information, please contact Paula Janiak at paula.janiak@amededu.com.
Who Should Attend?
This activity is intended for all HIV healthcare professionals. Specifically:
- HIV physicians experienced in treating HIV patients with limited treatment options in need of the latest information on new treatment options.
- HIV physicians inexperienced in treating patients with limited treatment options who need more comprehensive education on identifying and managing these patients with emphasis on new drugs;
- Clinical pharmacologists involved in the concomitant medication management and dose adjusting for co-morbidities of patients with limited treatment options;
- Other EU healthcare professionals (e.g. nurse practitioners) involved in the medical care of patients with limited treatment options.
- HIV physicians experienced in treating HIV patients with limited treatment options in need of the latest information on new treatment options.
- HIV physicians inexperienced in treating patients with limited treatment options who need more comprehensive education on identifying and managing these patients with emphasis on new drugs;
- Clinical pharmacologists involved in the concomitant medication management and dose adjusting for co-morbidities of patients with limited treatment options;
- Other EU healthcare professionals (e.g. nurse practitioners) involved in the medical care of patients with limited treatment options.
Meeting Objectives
The series aims to create an opportunity to educate HIV-treating clinicians on the optimal identification and management of HIV patients with limited treatment options, specifically addressing:
- Define patients with limited treatment options and tools to identify them;
- Understand key challenges and general considerations in the treatment of those patients;
- Understand the implications of drug resistance and co-morbidities in creating optimal treatment regimens;
- Increase knowledge of new treatment options available for these patients;
- Describe how best to integrate new drugs into optimal combination regimens.
- Define patients with limited treatment options and tools to identify them;
- Understand key challenges and general considerations in the treatment of those patients;
- Understand the implications of drug resistance and co-morbidities in creating optimal treatment regimens;
- Increase knowledge of new treatment options available for these patients;
- Describe how best to integrate new drugs into optimal combination regimens.
Learning Objectives
At the completion of this program participants will be able to:
- Define patients with limited treatment options and tools to identify them;
- Understand key challenges and general considerations in the treatment of those patients;
- Understand the implications of drug resistance and co-morbidities in creating optimal treatment regimens;
- Increase knowledge of new treatment options available for these patients;
- Describe how best to integrate new drugs into optimal combination regimens.
- Define patients with limited treatment options and tools to identify them;
- Understand key challenges and general considerations in the treatment of those patients;
- Understand the implications of drug resistance and co-morbidities in creating optimal treatment regimens;
- Increase knowledge of new treatment options available for these patients;
- Describe how best to integrate new drugs into optimal combination regimens.
Practical Information
Certificate of Attendance
A certificate of attendance will be sent to participants who successfully complete the program and post-meeting survey.
Language
This series is provided in several editions, including the following languages:
- German
- Italian
- Spanish
- German
- Italian
- Spanish
Disclaimer
This conference is intended for educational purposes only and aims to offer participants the opportunity to share information. The Organizing Secretariat of this event, Virology Education, cannot accept any liability for the scientific content of the sessions or for any claims which may result from the use of information or publications from this meeting. Virology Education disclaims all liability for injuries or losses of whatever nature incurred by individuals attending the conference.
Liability and Insurance
By registering for the conference participants agree that the organizers do not accept responsibility for medical-, travel- or personal insurance. Participants are advised to take out their own insurance policies.
Photographs, Audio, and Video Recording
Photographs, audio, and video recordings are not permitted at the official meeting sessions. Only the official medical writer appointed by the organization may make recordings. All presentations will be posted here as soon as possible after the workshop is finished, provided the speaker has given permission to do so.
Code of Conduct
All attendees, speakers, co-organizers, partners, endorsers, suppliers, volunteers, and employees at any of our programs are expected to observe our Code of Conduct. We cannot tolerate any form of discrimination, harassment, disrespect, or the marginalization of those involved in our programs. All participants of VE and AME-organized programs are expected to treat others with dignity and respect at all times.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Any individual who feels discriminated against, harassed, disrespected, or marginalized is encouraged to report the incident(s) to VE and AME via info@amededu.com or to one of our on-site personnel.
Any participant who is found to have exhibited any inappropriate conduct or behavior against others may be removed from the program.
Committees
Program Director
Local Chairs
Support
The Managing HIV Patients With Limited Treatment Options symposium is supported by an independent educational grant from ViiV Healthcare.
ViiV Healthcare was not involved in the development of content or selection of faculty for this educational activity.
Support Our Initiative
Financial backing helps us deliver an impactful meeting experience to the benefit of healthcare professionals.
This collaboration plays a vital role in both the organizational as well as scientific success of the program.
To show your commitment to the cause, get in touch with us for a tailored
support package by contacting Paula at Paula.Janiak@amededu.com or call +31 30 230 7140.
Benefits of Support
By supporting this program, we can offer the following advantages for your company.* Please contact us for the most recent support level benefits for this program.
- Symposium opportunities
- Non-commercial interviews with company representatives
- Verbal acknowledgement during the program
- Discounted and complimentary registrations for your representatives
- Company acknowledgement on digital meeting materials including but not limited to newsletters, flyers, the streaming platform, and our website
- Company acknowledgement on printed meeting materials including but not limited to banners and the program book
- Digital and printed advertising opportunities
- Social media shout-outs
- Logo on the conference bag
*Subject to the support level.
Previous Editions
Top-Rated Materials from Previous Edition
Georg Behrens, MD, PhD - Betreuung von HIV-Patienten mit eingeschränkten Therapieoptionen
Managing HIV Patients with Limited Treatment Options - EU Series 2022
Language
